Patient Follow-up

Follow-up telephone calls at 30 days will confirm patients’ consent to participate further in follow-up at 60 days and 6 and 12 months, and linkage to administrative data.
At follow-up, we will ascertain quality of life using the VR12 instrument, the WHO ordinal scale, gender-based variable, vaccine status, race, ethnicity, and other social factors. 
Patient partners are currently developing a questionnaire about patient experiences in self-isolation/quarantine.